Wullich B - Search Results

1

Silencing of the SEC62 gene inhibits migratory and invasive potential of various tumor cells.

Greiner M, Kreutzer B, Jung V, Grobholz R, Hasenfus A, Stöhr RF, Tornillo L, Dudek J, Stöckle M, Unteregger G, Kamradt J, Wullich B, Zimmermann R. Greiner M, et al. Among authors: wullich b. Int J Cancer. 2011 May 15;128(10):2284-95. doi: 10.1002/ijc.25580. Int J Cancer. 2011. PMID: 20669223

2

Comprehensive genotypic analysis of human prostate cancer cell lines and sublines derived from metastases after orthotopic implantation in nude mice.

Lensch R, Götz C, Andres C, Bex A, Lehmann J, Zwergel T, Unteregger G, Kamradt J, Stoeckle M, Wullich B. Lensch R, et al. Among authors: wullich b. Int J Oncol. 2002 Oct;21(4):695-706. Int J Oncol. 2002. PMID: 12239607

3

Managing locally advanced bladder cancer.

Lehmann J, Retz M, Siemer S, Kamradt J, Wullich B, Stöckle M. Lehmann J, et al. Among authors: wullich b. Expert Rev Anticancer Ther. 2002 Dec;2(6):656-66. doi: 10.1586/14737140.2.6.656. Expert Rev Anticancer Ther. 2002. PMID: 12503211 Review.

4

Evidence for gains at 15q and 20q in brain metastases of prostate cancer.

Wullich B, Riedinger S, Brinck U, Stoeckle M, Kamradt J, Ketter R, Jung V. Wullich B, et al. Cancer Genet Cytogenet. 2004 Oct 15;154(2):119-23. doi: 10.1016/j.cancergencyto.2004.01.005. Cancer Genet Cytogenet. 2004. PMID: 15474146

5

The measurement of complexed prostate-specific antigen has a better performance than total prostate-specific antigen.

Herrmann W, Stöckle M, Sand-Hill M, Hübner U, Herrmann M, Obeid R, Wullich B, Loch T, Geisel J. Herrmann W, et al. Among authors: wullich b. Clin Chem Lab Med. 2004;42(9):1051-7. doi: 10.1515/CCLM.2004.211. Clin Chem Lab Med. 2004. PMID: 15497472 Clinical Trial.

6

Transrectal ultrasound guided biopsy of the prostate: random sextant versus biopsies of sono-morphologically suspicious lesions.

Loch T, Eppelmann U, Lehmann J, Wullich B, Loch A, Stöckle M. Loch T, et al. Among authors: wullich b. World J Urol. 2004 Nov;22(5):357-60. doi: 10.1007/s00345-004-0462-4. Epub 2004 Dec 1. World J Urol. 2004. PMID: 15672278 Clinical Trial.

7

Application of a modified real-time PCR technique for relative gene copy number quantification to the determination of the relationship between NKX3.1 loss and MYC gain in prostate cancer.

Kindich R, Florl AR, Jung V, Engers R, Müller M, Schulz WA, Wullich B. Kindich R, et al. Among authors: wullich b. Clin Chem. 2005 Mar;51(3):649-52. doi: 10.1373/clinchem.2004.045013. Clin Chem. 2005. PMID: 15738520 No abstract available.

8

Relationship of NKX3.1 and MYC gene copy number ratio and DNA hypomethylation to prostate carcinoma stage.

Kindich R, Florl AR, Kamradt J, Lehmann J, Müller M, Wullich B, Schulz WA. Kindich R, et al. Among authors: wullich b. Eur Urol. 2006 Jan;49(1):169-75; discussion 175. doi: 10.1016/j.eururo.2005.09.012. Epub 2005 Nov 15. Eur Urol. 2006. PMID: 16310933

9

Genomic and expression analysis of the 3q25-q26 amplification unit reveals TLOC1/SEC62 as a probable target gene in prostate cancer.

Jung V, Kindich R, Kamradt J, Jung M, Müller M, Schulz WA, Engers R, Unteregger G, Stöckle M, Zimmermann R, Wullich B. Jung V, et al. Among authors: wullich b. Mol Cancer Res. 2006 Mar;4(3):169-76. doi: 10.1158/1541-7786.MCR-05-0165. Mol Cancer Res. 2006. PMID: 16547154

10

Protein transport into the endoplasmic reticulum: mechanisms and pathologies.

Zimmermann R, Müller L, Wullich B. Zimmermann R, et al. Among authors: wullich b. Trends Mol Med. 2006 Dec;12(12):567-73. doi: 10.1016/j.molmed.2006.10.004. Epub 2006 Oct 30. Trends Mol Med. 2006. PMID: 17071140

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

368 results

Search Page

Filters